Peptide library A–Z
38 compounds, each with a standard research page. Filter by what part of the body the research targets, or by how far the compound has actually progressed in human research.
38 compounds
- 5-Amino-1MQ5-amino-1-methylquinolinium; 5A1MQPhase 2
- AOD-9604Phase 2
- ARA-290Cibinetide; pyroglutamate helix B surface peptide (pHBSP)Phase 2
- BPC-157Body Protection Compound 157, pentadecapeptide BPC 157Preclinical
- CagrilintideAM833; the amylin component of CagriSemaPhase 3
- CartalaxAED peptide; Ala-Glu-AspPhase 2
- CerebrolysinPhase 3
- CJC-1295Modified GRF (1-29); with DACPreclinical
- DihexaPhase 2
- DSIPDelta sleep-inducing peptidePhase 2
- EpitalonEpithalonPreclinical
- Follistatin-344Preclinical
- GHK-CuCopper tripeptide-1Preclinical
- GLOW stackBPC-157 + TB-500 + GHK-Cu blendDiscovery
- GlutathioneGSH; gamma-glutamyl-cysteinyl-glycinePhase 2
- IGF-1 LR3Long R3 insulin-like growth factor 1Phase 2
- IpamorelinPhase 2
- KisspeptinKISS1 peptides; kisspeptin-54 and kisspeptin-10Phase 1
- KLOW stackKPV + BPC-157 + TB-500 + GHK-Cu blendDiscovery
- KPVLys-Pro-Val; the C-terminal tripeptide of alpha-MSHPhase 2
- L-CarnitineLevocarnitine; CarnitorApproved
- Melanotan IAfamelanotide; MT-1; the active peptide in ScenesseApproved
- MOTS-cPreclinical
- PE-22-28A shortened spadin analoguePhase 2
- PinealonGlu-Asp-Arg; EDR peptidePhase 2
- PT-141Bremelanotide, VyleesiApproved
- RetatrutideLY3437943; sometimes mislabelled 'GLP-3'Phase 3
- SelankPreclinical
- SemaglutideWegovy; Ozempic; RybelsusApproved
- SemaxPreclinical
- SermorelinApproved
- SS-31ElamipretidePreclinical
- TB-500Thymosin beta-4 fragmentPreclinical
- TesamorelinEgriftaApproved
- Thymosin alpha-1ZadaxinPhase 3
- TirzepatideZepbound; MounjaroApproved
- Vasoactive intestinal peptideVIP; synthetic form: aviptadilApproved
- Wolverine stackBPC-157 + TB-500 blendDiscovery